126 related articles for article (PubMed ID: 21176720)
1. An assessment of teicoplanin use and monitoring serum levels in a Chinese teaching hospital.
Dong YL; Dong HY; Hu SS; Wang X; Wei YX; Wang MY; Dong WH; Yao HP; You HS; Xing JF
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):14-22. PubMed ID: 21176720
[TBL] [Abstract][Full Text] [Related]
2. Measurement of Teicoplanin Concentration With Liquid Chromatography-Tandem Mass Spectrometry Method Demonstrates the Usefulness of Therapeutic Drug Monitoring in Hematologic Patient Populations.
Chae H; Lee JJ; Cha K; Her SH; Kim HY; Han E; Kim M; Kim Y; Cho SY; Lee DG
Ther Drug Monit; 2018 Jun; 40(3):330-336. PubMed ID: 29746433
[TBL] [Abstract][Full Text] [Related]
3. Interlaboratory analysis of teicoplanin plasma concentration assays among Chinese laboratories.
Wang XX; Jin PF; Li PM; Xu S; Kong XD; Qin W; Chen WQ; Qin WJ; Zhang XL
J Clin Pharm Ther; 2020 Oct; 45(5):983-990. PubMed ID: 31985852
[TBL] [Abstract][Full Text] [Related]
4. Assay of teicoplanin in serum: comparison of high-performance liquid chromatography and fluorescence polarization immunoassay.
McCann SJ; White LO; Keevil B
J Antimicrob Chemother; 2002 Jul; 50(1):107-10. PubMed ID: 12096014
[TBL] [Abstract][Full Text] [Related]
5. Teicoplanin pharmacokinetics in critically ill paediatric patients.
Sánchez A; López-Herce J; Cueto E; Carrillo A; Moral R
J Antimicrob Chemother; 1999 Sep; 44(3):407-9. PubMed ID: 10511412
[TBL] [Abstract][Full Text] [Related]
6. Development of initial loading procedure for teicoplanin in critically ill patients with severe infections.
Matsumoto K; Kanazawa N; Watanabe E; Yokoyama Y; Fukamizu T; Shimodozono Y; Maeda C; Yasuda T; Kakihana Y; Ikawa K; Morikawa N; Takeda Y
Biol Pharm Bull; 2013; 36(6):1024-6. PubMed ID: 23727923
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of teicoplanin using an LC-MS/MS method: Analysis of 421 measurements in a naturalistic clinical setting.
Jung J; Lee K; Oh J; Choi R; Woo HI; Park HD; Kang CI; Kim YJ; Lee SY
J Pharm Biomed Anal; 2019 Apr; 167():161-165. PubMed ID: 30776754
[TBL] [Abstract][Full Text] [Related]
8. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level.
Sato M; Chida K; Suda T; Muramatsu H; Suzuki Y; Hashimoto H; Gemma H; Nakamura H
J Infect Chemother; 2006 Aug; 12(4):185-9. PubMed ID: 16944256
[TBL] [Abstract][Full Text] [Related]
9. Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.
Matsumoto K; Kanazawa N; Ikawa K; Fukamizu T; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
J Infect Chemother; 2010 Jun; 16(3):193-9. PubMed ID: 20195882
[TBL] [Abstract][Full Text] [Related]
10. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
Wang JT; Liao HI; Wu Lin FL; Chang SC
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
[TBL] [Abstract][Full Text] [Related]
11. Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections.
Wang T; Li N; Hu S; Xie J; Lei J; Wang Y; Zheng X; Xing J; Dong Y
Int J Clin Pharmacol Ther; 2015 May; 53(5):356-62. PubMed ID: 25828639
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for decreased teicoplanin trough concentrations during initial dosing in critically ill patients.
Yoshida T; Yoshida S; Okada H; Suzuki A; Niwa T; Suzuki K; Ohmori T; Kobayashi R; Baba H; Suzuki K; Murakami N; Itoh Y; Ogura S
Pharmazie; 2019 Feb; 74(2):120-124. PubMed ID: 30782263
[No Abstract] [Full Text] [Related]
13. Therapeutic Drug Level Monitoring of Teicoplanin in Korean Pediatric Patients with Normal versus Impaired Renal Function.
Choi JS; Kim JM; Kim D; Kim SH; Cho H; Park HD; Lee SY; Kang CI; Kim YJ
J Korean Med Sci; 2020 Nov; 35(46):e376. PubMed ID: 33258328
[TBL] [Abstract][Full Text] [Related]
14. Measurement of teicoplanin by liquid chromatography-tandem mass spectrometry: development of a novel method.
Fung FH; Tang JC; Hopkins JP; Dutton JJ; Bailey LM; Davison AS
Ann Clin Biochem; 2012 Sep; 49(Pt 5):475-81. PubMed ID: 22875013
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
[TBL] [Abstract][Full Text] [Related]
16. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
Brink AJ; Richards GA; Cummins RR; Lambson J;
Int J Antimicrob Agents; 2008 Nov; 32(5):455-8. PubMed ID: 18718742
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
Tsai IL; Sun HY; Chen GY; Lin SW; Kuo CH
Talanta; 2013 Nov; 116():593-603. PubMed ID: 24148450
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.
Rouveix B; Jehl F; Drugeon H; Brumpt I; Caulin E
Antimicrob Agents Chemother; 2004 Jul; 48(7):2394-9. PubMed ID: 15215086
[TBL] [Abstract][Full Text] [Related]
19. Optimal teicoplanin loading regimen to rapidly achieve target trough plasma concentration in critically ill patients.
Li H; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Zhang Y; Wang T; Shi Q
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):277-288. PubMed ID: 31608579
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy.
Kim SH; Kang CI; Huh K; Cho SY; Chung DR; Lee SY; Kim YJ; Peck KR
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2113-2120. PubMed ID: 31372903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
